Charles Gersbach

Charles Gersbach

Signal active

Co-Founder & Scientific Advisor

Bio

Dr. Charles A. Gersbach is the Rooney Family Associate Professor of Biomedical Engineering at Duke University, as well as the Director of the Duke Center for Biomolecular and Tissue Engineering. He also has appointments in the Duke University Medical Center in the Department of Orthopaedic Surgery and the Center for Genomic and Computational Biology. His research interests are in the areas of genome and epigenome editing, gene therapy, biomolecular and cellular engineering, regenerative medicine, synthetic biology, and genomics. Dr. Gersbach received his Bachelor’s degree in Chemical Engineering from the Georgia Institute of Technology and his Ph.D. in Biomedical Engineering from the Georgia Institute of Technology and Emory University School of Medicine focusing on the genetic reprogramming of adult stem cells for musculoskeletal tissue regeneration. Dr. Gersbach completed his postdoctoral training at The Scripps Research Institute in molecular biology and biochemistry, focusing on developing new genome editing tools with applications in biotechnology and gene therapy. Dr. Gersbach’s laboratory at Duke University is focused on applying molecular and cellular engineering to applications in gene therapy, regenerative medicine, and basic science. In particular, his research aims to develop new methods to genetically modify genome sequences and cellular gene networks in a precise and targeted manner. These new methods are then applied to correction of genetic diseases, directing stem cell differentiation, regeneration of damaged tissues, or answering fundamental biological questions regarding gene regulation and genome structure and function. Examples of technologies used in his research include genome and epigenome editing, protein engineering, directed evolution, genetic reprogramming, gene delivery, and optogenetics. Dr. Gersbach’s recognitions include the NIH Director’s New Innovator Award, the National Science Foundation CAREER Award, the Hartwell Foundation Individual Biomedical Research Award, the March of Dimes Basil O’Connor Scholar Award, and the Outstanding New Investigator Award from the American Society of Gene and Cell Therapy.

Location

N/A

Social

Primary Organization

Locus Biosciences

Locus Biosciences

Founded

2015

Employees

51-100

Industry

Biotechnology, Biopharma, Therapeutics

Jobs history

2

Tune Therapeutics

Board Member

Invalid date - Current

Tune Therapeutics

Co-Founder, Acting Chief Scientific Officer, Director

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Charles Gersbach is the Co-Founder & Scientific Advisor at Locus Biosciences, based in United States, North America. With a background in Biotechnology, Charles Gersbach has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

0

There is no partner investment available on this profile

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.